This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: Insilico Medicine IP Limited. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Artur Kadurin: Innovator in Adversarial Autoencoders
Introduction
Artur Kadurin is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of machine learning and drug discovery through his innovative patents. With a total of 3 patents, Kadurin is recognized for his work in developing advanced methodologies that enhance the generation of objects with specific properties.
Latest Patents
One of Kadurin's latest patents is titled "Mutual Information Adversarial Autoencoder." This method involves generating an object by processing a dataset that includes object data and condition data. The process entails obtaining latent object data, latent condition data, and comparing these to determine differences, ultimately leading to the generation of new object data.
Another notable patent is "Entangled Conditional Adversarial Autoencoder for Drug Discovery." This method focuses on generating new objects with desired properties, such as specific bioactivity. It includes receiving objects and their properties, training a machine learning model, and outputting new objects that differ from the original dataset. This innovation is particularly relevant in the development of potential active agents, including small molecule drugs and biological agents.
Career Highlights
Artur Kadurin is currently employed at Insilico Medicine IP Limited, where he continues to push the boundaries of research in artificial intelligence and drug discovery. His work is instrumental in advancing the capabilities of machine learning applications in the pharmaceutical industry.
Collaborations
Kadurin collaborates with notable colleagues, including Daniil Polykovskiy and Aleksandr M Aliper. Their combined expertise contributes to the innovative projects at Insilico Medicine, fostering a collaborative environment that enhances research outcomes.
Conclusion
Artur Kadurin's contributions to the field of machine learning and drug discovery through his patents demonstrate his innovative spirit and commitment to advancing technology. His work continues to influence the development of new methodologies that have the potential to revolutionize the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile